Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-11,950
Closed -$1.19M 501
2019
Q3
$1.19M Sell
11,950
-173
-1% -$16.4K 0.12% 210
2019
Q2
$1.12M Buy
12,123
+541
+5% +$51.4K 0.11% 218
2019
Q1
$1.09M Buy
11,582
+4,830
+72% +$422K 0.12% 201
2018
Q4
$433K Sell
6,752
-3,007
-31% -$222K 0.06% 277
2018
Q3
$873K Buy
9,759
+1,318
+16% +$116K 0.09% 239
2018
Q2
$670K Hold
8,441
0.07% 263
2018
Q1
$753K Buy
8,441
+5,050
+149% +$485K 0.08% 249
2017
Q4
$354K Buy
+3,391
New +$383K 0.04% 336

Other funds holding CELG

USCA RIA's CELG Position: Q4 2019 in Review

USCA RIA sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,950 shares — an estimated $1.19M sold.

USCA RIA first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $1.19M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • USCA RIA reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • USCA RIA sold 11,950 Celgene Corp shares in Q4 2019, an estimated $1.19M.
  • USCA RIA first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • USCA RIA's Celgene Corp position peaked at $1.19M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on USCA RIA's 13F filing for Q4 2019, filed 27 Jan 2020.